Article
Study on the mechanism of Euscaphic acid in the treatment of non-Hodgkin lymphoma based on network pharmacology and molecular docking
2024-02-09
Abstract excerpt
Non-Hodgkin's lymphoma (NHL) is a highly heterogenous disease. 5-year survival duration after diagnosis is poor among patients with aggressive/relapsing form of NHL. Our previous research found for the first time that Euscaphic acid (EA) has anti-tumor effects in NHL. However, the underlying mechanism by which EA plays a role in NHL remains unclear. In this study, we used network pharmacology and molecular docking...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cholesterol and Lipid Metabolism
- Cytokine Signaling Pathways and Interactions
- Ferroptosis and cancer prognosis
- Natural product bioactivities and synthesis
- Rheumatoid Arthritis Research and Therapies
- Steroid Chemistry and Biochemistry
Identifiers and source
- Literature Corpus work
- 4470943a-db6a-52b9-96a7-2ec7e302b00e
- DOI
- 10.21203/rs.3.rs-3926002/v1
